D201902 – Proteomic analysis of blood cells of sickle cell patients before and after gene therapy Patrick Mayeux
T201902 – Quality control of advanced therapy products and biological monitoring of patients post gene therapies Capucine Picard
T201901 – Monitoring of the gene therapy efficiency and study of the immunological reconstitution of patients with immune deficits by determining the copy number into the cells Alessandra Magnani
D201901 – Development of an in vitro model for cerebral vasculopathy monitoring in gene therapy of sickle cell disease Pablo Bartolucci
D201801 – Study of erythropoiesis and circulating red blood cells in gene therapy for sickle cell disease Wassim El Nemer
D201702 – Preclinical development of new lentiviral vectors and gene therapy strategies to treat sickle cell disease Annarita Miccio
